showed that hypophosphatemia often occurs during CRRT, with an incidence of up to 59%
However, these drugs are known to cause a plethora of adverse effects such as weight gain, edema, intestinal discomfort and hypoglycemia (2)
According to the researchers, the findings suggest that semaglutide could potentially address both aspects of the condition simultaneously, by improving metabolic health while also supporting reproductive function
GLP-1 agonists directly bind to and activate GLP-1 receptors on pancreatic cells, while berberine works primarily through AMPK activation and does not directly interact with GLP-1 receptors
However, this compensatory increase in FAO can lead to mitochondrial overloading and subsequent damage, resulting in increased oxidative stress and inflammatory responses [45, 46]
Clinical trials reveal that DSIP injections significantly reduce ACTH levels in plasma for several hours with minimal impact on cortisol (3)